Purchase Dimethylphenidate
Discount program, second-order - 5%OFF, third-order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy Dimethylphenidate for sale
Dimethylphenidate, popularly known as Ritalin, is a stimulant of the central nervous system (CNS) used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. However, the drug's potential for misuse and how it activates the CNS have made it a subject of considerable debate and discussion. This page examines the history, mechanism of action, and effects of dimethylphenidate, as well as its possible hazards and advantages.
History of Dimethylphenidate
First produced in 1944, dimethylphenidate was licensed by the US Food and Drug Administration (FDA) for treating narcolepsy and attention deficit disorder in 1955. It has now been used to treat various illnesses, including depression, obesity, and sleep difficulties, in addition to ADHD.
Mechanism of Action
Dimethylphenidate is a prodrug, meaning that it is transformed into its active form after administration. The body metabolizes dimethylphenidate into two active metabolites: amphetamine and methamphetamine. These metabolites are accountable for the stimulating effects of the medication on the CNS.
Uncertainty surrounds the precise process through which dimethylphenidate delivers its effects. However, it is thought that the medicine increases the neurotransmitters dopamine and norepinephrine released in the brain, resulting in greater attention, alertness, and decreased weariness.
Effects of Dimethylphenidate
Dimethylphenidate's effects might vary according to dosage and individual characteristics such as age, weight, and tolerance. The medication has various effects, including increased alertness, concentration, wakefulness, decreased hunger, and enhanced mood.
At greater dosages, dimethylphenidate can elicit more acute symptoms, including agitation, anxiety, a rapid heart rate, and hyperactivity. In certain instances, the medicine may also cause significant adverse effects, including hallucinations, paranoid delusions, and fast mood changes.
Potential Risks and Benefits of Dimethylphenidate
Dimethylphenidate is a potent medication with both possible hazards and advantages. On the one hand, medicine can be a helpful therapy for diseases such as ADHD and narcolepsy, aiding patients in focusing and remaining awake.
On the other hand, the drug's propensity for misuse and how it activates the CNS can result in adverse effects such as addiction, overdose, and severe side effects. In addition, long-term usage of dimethylphenidate can result in tolerance, wherein greater dosages are necessary to get the same effects, and dependence, wherein discontinuing the medication may cause withdrawal symptoms.
Questions asked frequently
What is the function of dimethylphenidate?
Medical practitioners use dimethylphenidate to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.
How does dimethylphenidate work?
Dimethylphenidate is a prodrug that is metabolized in the body to generate two active metabolites, amphetamine and methamphetamine, which are responsible for the stimulant effects of the drug on the central nervous system (CNS).
What impacts does dimethylphenidate have?
Depending on the dose and individual conditions, the effects of dimethylphenidate might vary. Still, in general, the medication generates various effects, including enhanced alertness, attention, and wakefulness, decreased hunger, and improved mood.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
100g $600
1kg $1690
1kg $1590
1kg $1690
out of stock
out of stock
out of stock
500g $1080
1kg $1690
100mg $840
300g $850
1kg $1890